Abstract
Hypertension is among the common and leading causes of morbidity and mortality throughout the globe. The biological process of hypertension involves multiple physiological pathways, each of which may be affected by multiple gene products. But the mechanisms under this difference are still not full understood. In recent years, some evidence has been found supporting the involvement of epigenetic mechanisms in many cardiovascular diseases and others. We hypothesised that epigenetic mechanisms have been also involved in essential hypertension possibly by suppression of and changing the relational genes with essential hypertension.
Keywords: Epigenetic mechanisms, Essential hypertension, DNA methylation, Hypertension, cardiovascular diseases, obesity, diabe-tes, hyperlipidemia, Epigenetics, DNA, histone code, DNA methyl-transferases, methyl-CpG binding proteins, insulator pro-teins, histone-modifying enzymes, chromatin-remodelling complexes, cancer, autoimmune disorders, CpG, Estrogen receptor expression, DNA methyltrans-ferase, histone deacetylase inhibition, AT1b gene, 11b-HSD2(HSD11B2), sodium retention, hypokalaemia, 11 beta-hydroxysteroid dehydrogenase 2, tetrahydrocortisone-metabolites, HSD11B2, 5-aza-2-deoxycytidine, procainamide, endo-thelin-converting enzyme, 5-AZA-CdR acti-vates, methylated b1-AR gene promoter, H9c2 myocar-dial, antihypertensive response, SERPINA3, Smoking, Mito-fusin-2, Ras inhibitor, anti-proliferative effects, hypermethylation, Mfn-2
Current Hypertension Reviews
Title: Role of Epigenetic Regulatory Mechanisms in the Mechanism of Essential Hypertension
Volume: 6 Issue: 4
Author(s): Zhong Guang-Wei, Luo Yan-Hong, Li Wei, Zhong Chang-Gao and Zhang Cheng
Affiliation:
Keywords: Epigenetic mechanisms, Essential hypertension, DNA methylation, Hypertension, cardiovascular diseases, obesity, diabe-tes, hyperlipidemia, Epigenetics, DNA, histone code, DNA methyl-transferases, methyl-CpG binding proteins, insulator pro-teins, histone-modifying enzymes, chromatin-remodelling complexes, cancer, autoimmune disorders, CpG, Estrogen receptor expression, DNA methyltrans-ferase, histone deacetylase inhibition, AT1b gene, 11b-HSD2(HSD11B2), sodium retention, hypokalaemia, 11 beta-hydroxysteroid dehydrogenase 2, tetrahydrocortisone-metabolites, HSD11B2, 5-aza-2-deoxycytidine, procainamide, endo-thelin-converting enzyme, 5-AZA-CdR acti-vates, methylated b1-AR gene promoter, H9c2 myocar-dial, antihypertensive response, SERPINA3, Smoking, Mito-fusin-2, Ras inhibitor, anti-proliferative effects, hypermethylation, Mfn-2
Abstract: Hypertension is among the common and leading causes of morbidity and mortality throughout the globe. The biological process of hypertension involves multiple physiological pathways, each of which may be affected by multiple gene products. But the mechanisms under this difference are still not full understood. In recent years, some evidence has been found supporting the involvement of epigenetic mechanisms in many cardiovascular diseases and others. We hypothesised that epigenetic mechanisms have been also involved in essential hypertension possibly by suppression of and changing the relational genes with essential hypertension.
Export Options
About this article
Cite this article as:
Guang-Wei Zhong, Yan-Hong Luo, Wei Li, Chang-Gao Zhong and Cheng Zhang, Role of Epigenetic Regulatory Mechanisms in the Mechanism of Essential Hypertension, Current Hypertension Reviews 2010; 6 (4) . https://dx.doi.org/10.2174/157340210793611686
DOI https://dx.doi.org/10.2174/157340210793611686 |
Print ISSN 1573-4021 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6506 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Oral Anticoagulants in Peripheral Arterial and Coronary Artery Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Guide of Hypertensive Crisis Pharmacotherapy
Cardiovascular & Hematological Disorders-Drug Targets Characterization of Mitogen-Activated Protein Kinase Expression in Nucleus Accumbens and Hippocampus of Rats Subjected to Food Selection in the Cafeteria Diet Protocol
CNS & Neurological Disorders - Drug Targets Obstructive Sleep Apnea and Atrial Arrhythmogenesis
Current Cardiology Reviews Anti-Angiogenesis Drugs in Diabetic Retinopathy
Current Pharmaceutical Biotechnology Common Therapeutic Strategies in the Management of Sexual Dysfunction and Cardiovascular Disease
Current Drug Targets - Cardiovascular & Hematological Disorders Current Strategies and Future Perspective for the Effective Treatment of Diabetic Retinopathy
Current Drug Therapy Ambulatory Blood Pressure Monitoring in Type 2 Diabetes Mellitus: A Cross-sectional Study
Current Hypertension Reviews Predicting the Activity of ACE Inhibitory Peptides with a Novel Mode of Pseudo Amino Acid Composition
Protein & Peptide Letters Early Hematoma Enlargement in Primary Intracerebral Hemorrhage
Current Drug Targets Management of Hemorrhoidal Disease in Special Conditions: A Word of Caution
Reviews on Recent Clinical Trials Diuretic-Associated Electrolyte Disorders in the Elderly: Risk Factors, Impact, Management and Prevention
Current Drug Safety Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157
Current Pharmaceutical Design Editorial [Hot Topic:Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design Weight Loss in Obesity and Metabolic Syndrome
Current Hypertension Reviews Treatment of Atherosclerotic Renovascular Disease
Current Hypertension Reviews Angiotensin II Type 1 and Type 2 Receptor-induced Cell Signaling
Current Pharmaceutical Design Molecular Basis of Inflammation and Insulin Resistance in Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Halogen Dance Reaction and its Application in Organic Synthesis
Current Organic Chemistry Oxidative Stress as a Regulator of Murine Atherosclerosis
Current Drug Targets